Itex Ceftriaxone Sodium Injection 2g

Adult administration

Adults and children over 12 years of age: Administer 1-2 g (potency) once daily via intravenous or intramuscular injection. For infections caused by severe pathogens or moderately susceptible bacteria, the dose may be increased to 4 g (potency) once daily. Elderly patients: Follow adult dosage without alteration. Gonorrhea: For treatment of gonorrhea caused by penicillin-sensitive and resistant bacteria, a single dose of 250 mg (potency) is recommended.

Child administration

Neonates (within 14 days of birth): Administer 20-50 mg (potency) per kg of body weight once daily, not exceeding 50 mg (potency) per kg. There is no distinction between premature infants and term infants. Young children and infants

This medication should not be used with calcium-containing solutions. If administered concomitantly with a calcium-containing solution, there is a risk of fatal precipitation in newborns. This medication may pose risks when used in newborns, particularly those born preterm or with a short gestation period, and should not be administered. Additionally, individuals allergic to this medication or to cephalosporins or penicillins should not use it. If it contains lidocaine, it should not be administered intravenously, and patients with impaired kidney function may require dosage adjustments. During administration, watch carefully for adverse effects such as allergic reactions, gastrointestinal disturbances, liver function anomalies, and kidney disorders. Rarely, serious skin reactions or neurological abnormalities such as encephalopathy may occur. To prevent the development of resistant bacteria, this medication should only be administered for the necessary duration, with close observation of the patient's condition after administration. Pregnant or breastfeeding women should consult a physician before using this medication as its safety is not assured. Elderly patients may experience more pronounced side effects due to diminished physiological functions, necessitating careful monitoring during administration. This medication may affect blood test results, necessitating reference during testing, particularly with blood glucose tests or urine glucose tests where errors may arise. During administration, there may be pain, inflammation, or phlebitis at the injection site; thus, injection technique and speed must be carefully adjusted. This medication can interact with other antibiotics or drugs, so any combination of medications should always follow expert guidelines. Once prepared, this medication should be used as soon as possible, and proper temperature and duration must be adhered to for storage to maintain its efficacy and safety.

Serious side effects

Hives, severe swelling (edema), cold sweats, chest tightness, difficulty breathing, severe allergic reactions, high fever with severe rash, blisters, skin peeling, pain in oral/conjunctival mucosa, severe skin adverse reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, liver anomalies (jaundice), sudden and severe headache

Mild side effects

• Eosinophilia
• leukopenia
• thrombocytopenia
• diarrhea
• rash
• increased liver enzymes
• headache
• dizziness
• bronchospasm
• loose stools

This medication should be stored in a sealed container to prevent exposure to air or moisture. It is important to maintain storage temperatures between 1 and 30 degrees Celsius. This will help prolong the medication's effectiveness.

Appearance

A colorless, transparent vial filled with crystalline powder that is white to light yellow.

Package unit

10 vials (2g/vial x 10)